Legal 500
  • Rankings

    • Jurisdictions

    • Submissions

    • Future Lawyers

  • Firms & Lawyers

    • Service Providers

    • Barristers’ Sets

    • Networks

    • Interview with…

  • In-House

    • In-House Content

    • GC Powerlist

  • Knowledge Centre

    • Data Products

    • Legal Business

    • News & Developments

    • About us

      • Legal 500

      • FAQs

      • Marketing

      • Careers

      • Contact us

  • Comparative Guides

  • Events

  • Legal 500 TV

About us

  • Legal 500

  • FAQs

  • Marketing

  • Careers

  • Contact us

  • Deutschland DE

  • Paris FR

  • Rankings

    • Jurisdictions

    • Submissions

    • Future Lawyers

  • Firms & Lawyers

    • Service Providers

    • Barristers’ Sets

    • Networks

    • Interview with…

  • In-House

    • In-House Content

    • GC Powerlist

  • Knowledge Centre

    • Data Products

    • Legal Business

    • News & Developments

    • About us

      • Legal 500

      • FAQs

      • Marketing

      • Careers

      • Contact us

  • Comparative Guides

  • Events

  • Legal 500 TV

About us

  • Legal 500

  • FAQs

  • Marketing

  • Careers

  • Contact us

  • Deutschland DE

  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Data Protection policies
  • Cookies Policy
  • Contact Us
  • Article

    Patentability Of Genetically Modified Plant Breeds: The Monsanto Conclusion

    The apex court then went onto examine Section 64 of the Act, dealing with revocation of patents
    IndiaIntellectual Property
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    Patentability Of Medical, Diagnostic, And Therapeutic Methods

    It's sometimes better to think about the things that cannot be patented to get a sense of the contours of patentability. Article 27.1 of the TRIPS Agreement states that patents must be available...
    IndiaIntellectual Property
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    Pharmaceutical Trademark And Its Conflict With Trademark Law

    Out of the many trademarks registered every year, the Indian pharmaceutical industry accounts for a major portion compared to the other sectors.
    IndiaIntellectual Property
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    Qualcomm's Loss In IP Licensing

    Qualcomm faced a setback from the US federal trade commission after it ruled that the latter is making undue advantage of its dominant position in the field of chip manufacturing, an essential part of cell phones.
    IndiaIntellectual Property
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    TM And Design Patent Conflict

    For long, when we compare the trademark with that of a design, the inclusion of trademark in the design was not meant much when we talk about the design patent infringement analysis.
    IndiaIntellectual Property
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    To Patent, Or Not To Patent, That Is The Question

    The granting of secondary use patents in the pharmaceutical industry has become more prominent after the negotiations of the TRIPS Agreement in 1995.
    IndiaIntellectual Property
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    Understanding Copyright Protection In India: Scope, Eligibility, And Limitations

    Copyright protection in India is provided under the Indian federal law, copyright Act of 1957 and has been used since its inception numerous amendments were adopted to suit the requirement of technological
    IndiaIntellectual Property
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    What Should Be Your Key Considerations While Licensing From Patent Pledges?

    Toyota, a Japanese MNC recently decided to grant approximately 24,000 ‘vehicle electrification' patent licenses on the technologies used by them in making of their cars, specifically
    IndiaIntellectual Property
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    Why Patent Translation Is Important

    Patent translation is an important part for an applicant who wishes to register their patent in multiple jurisdictions, translating it with utmost precision.
    IndiaIntellectual Property
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    Tax Structure On Fantasy Sports Sector In India

    Over the past several years, the Indian Fantasy Sports (FS) industry has seen substantial expansion.
    IndiaMedia, Telecoms, IT, Entertainment
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    India's Data Protection Board: The Enforcer That Isn't There Yet

    The data protection law of India has been in development for many years and is currently at a crucial point.
    IndiaPrivacy
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    Effect Of Insolvency And Bankruptcy Code Amendment On Home Buyers

    Real Estate Sector in India is one of the few sectors that have witnessed exponential growth in the last two decades.
    IndiaReal Estate and Construction
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    A Digital 'Jhakaas': What Denmark's Deepfake Law Means For India

    Imagine a world where your favourite actor's "Jhakaas" catchphrase is convincingly mimicked in a video, not by a skilled impressionist, but by a soulless algorithm.
    IndiaTechnology
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    Deepfakes And The Future Of Personality Rights In Indian Law

    The rapid growth of artificial intelligence has brought many creative opportunities, but it has also opened the door to one of the biggest modern threats to identity: deepfakes.
    IndiaTechnology
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    NFTs In Singapore

    In order to buy and sell digital artwork, NFTs are growing in popularity. This enables artists to monetize their original work, which would otherwise be easily reproduced.
    SingaporeTechnology
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    HIV-Drug Patent Wars In Thailand

    This blog covers the role that patents play in access to pharmaceuticals - HIV/AIDS in Thailand along with steps taken by government to overcome from current status of HIV/AIDS drugs
    ThailandIntellectual Property
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    Protection Of Plant Varieties In The UAE

    The first reform regarding the plant varieties in the UAE happened after 1991. Even after more than twenty-five years of reforms, the protection is still controversial.
    United Arab EmiratesIntellectual Property
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    Labelling While Exporting From The US

    With "voluntary" marking and labelling practices, there are standards and limitations that apply.
    United StatesIntellectual Property
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    U.S. Jury Upheld Validity Of Two Patents For Amgen Inc's Cholesterol-Lowering Drug Repatha® (Evolocumab)

    US healthcare giant Amgen has successfully defended two of its patents related to cholesterol-lowering drug Repatha® (evolocumab).
    United StatesIntellectual Property
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys
  • Article

    Protection Of Computer Programs In Vietnam

    According to the Vietnamese laws, the copyright protection of computer programs contravenes the prerequisite requirement of originality of protected works because practically, many computer programs...
    VietnamIntellectual Property
    Khurana & Khurana, Advocates and IP Attorneys
    Khurana & Khurana, Advocates and IP Attorneys

Showing 461–480 of 1789 results

PreviousNext
Legal Intelligence Newsletters